Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data.

Authors:
Malek FA; Funk P.

Journal:
Front Pharmacol

Publication Year: 2024

DOI:
10.3389/fphar.2024.1335309

PMCID:
PMC10920291

PMID:
38464728

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Front Pharmacol

Detailed journal information not available.

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflict of interest Authors FM and PF were employed by Dr. Willmar Schwabe GmbH & Co. KG."

Funding Disclosure

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Dr. Willmar Schwabe GmbH and Co. KG, Karlsruhe, Germany, sponsored this research and funded its publication. The authors thank Dr. Andreas Völp, Psy Consult Scientific Services, Hamburg, Germany, for providing medical writing support/editorial support, which was funded by Dr. Willmar Schwabe GmbH and Co. KG, Karlsruhe, Germany. Final decision to submit the manuscript for publication remained with the authors. The funder was involved in study design, analysis, and preparation of the manuscript."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025